ICER Panel Reaffirms Cost-Effectiveness Of GLP-1 Weight Loss Agents; Budgetary Impact Still An Issue, Even At New Medicare Pricing, ICER Staff Suggests

You must be a logged-in member of this site to view this article.

To request more information about a company license to the Prevision Policy continuous information service or to get further details about the services we offer, please click here.

Alternatively, if your organization already has a license and you do not yet have an account, please click here to request access.